Drug‐Induced Acute Pancreatitis: A Real‐World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database

Documenti analoghi

• Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data
  di: Natalia Sauer, et al.
  Pubblicazione: (2026)
• FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception
  di: Emanuel Raschi, et al.
  Pubblicazione: (2025)
• Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
  di: Anu Patel, et al.
  Pubblicazione: (2024)
• Respiratory Disorders Associated with Antibody–Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases
  di: Victor Mirleau, et al.
  Pubblicazione: (2025)
• Analysis of Real‐World Data Utilization in the Orphan Drug Approval Process: Focusing on New Drug Marketing Applications Submitted to the FDA
  di: Minji Kim, et al.
  Pubblicazione: (2026)